BAA TOXWP 118/CTP-2022-112800 -EVALUATE AND PROMOTE THE USE OF CELL- AND TISSUE-BASED ASSAYS THAT MORE ACCURATELY REPRESENT HUMAN SUSCEPTIBILITY THAN ANIMAL MODELS TO ADVERSE REACTIONS AND PREDICT THRESHOLD OF TOXICOLOGICAL CONCERNS RESULTING FROM EX

DEFINITIVE CONTRACT won by GEORGIA TECH RESEARCH CORP · work in SILVER SPRING, MD
$2,014,369
RecipientGEORGIA TECH RESEARCH CORP UEI EMW9FC8J3HN4
Award ID75F40122C00146
Award amount$2,014,369
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Food and Drug Administration
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN11
Set-asideUnrestricted
Start dateSep 28, 2022
End dateSep 29, 2025
Place of performanceSILVER SPRING, MD
Record updatedAug 12, 2025

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids